# Chemed Corp: financial statements, quarterly

CHE · NYSE · CIK 19584 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/che.md) · [Financials](/companies/che/financials.md) · [Filings](/companies/che/filings.md) · [Insiders](/companies/che/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/che/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [350 d](/filings/0001562762-25-000038.md) | [354](/filings/0001562762-24-000106.md) | [375](/filings/0001562762-24-000183.md) | [391](/filings/0001562762-24-000248.md) | [411 d](/filings/0001562762-25-000038.md) | [647](/filings/0000019584-26-000012.md) | [619](/filings/0000019584-26-000020.md) | [625](/filings/0000019584-26-000024.md) | [639 d](/filings/0001562762-26-000020.md) | [658](/filings/0000019584-26-000012.md) | [673](/filings/0000019584-26-000020.md) | [691](/filings/0000019584-26-000024.md) |
| Cost of revenue | $m | [358 d](/filings/0001562762-26-000020.md) | [385](/filings/0001562762-25-000096.md) | [390](/filings/0001562762-25-000186.md) | [396](/filings/0000019584-25-000006.md) | [406 d](/filings/0001562762-26-000020.md) | [431](/filings/0000019584-26-000012.md) | [434](/filings/0000019584-26-000020.md) | [425](/filings/0000019584-26-000024.md) | [417 d](/filings/0001562762-26-000020.md) | [442](/filings/0000019584-26-000012.md) | [452](/filings/0000019584-26-000020.md) | [458](/filings/0000019584-26-000024.md) |
| Selling, general and administrative | $m | [100 d](/filings/0001562762-26-000020.md) | [116](/filings/0001562762-25-000096.md) | [102](/filings/0001562762-25-000186.md) | [102](/filings/0000019584-25-000006.md) | [104 d](/filings/0001562762-26-000020.md) | [106](/filings/0000019584-26-000012.md) | [100](/filings/0000019584-26-000020.md) | [106](/filings/0000019584-26-000024.md) | [106 d](/filings/0001562762-26-000020.md) | [114](/filings/0000019584-26-000012.md) | [115](/filings/0000019584-26-000020.md) | [111](/filings/0000019584-26-000024.md) |
| Operating income | $m | [111 d](/filings/0001562762-26-000020.md) | [72.3](/filings/0001562762-25-000096.md) | [88.1](/filings/0001562762-25-000186.md) | [92.2](/filings/0000019584-25-000006.md) | [114 d](/filings/0001562762-26-000020.md) | [94.8](/filings/0000019584-26-000012.md) | [68.1](/filings/0000019584-26-000020.md) | [74.8](/filings/0000019584-26-000024.md) | [101 d](/filings/0001562762-26-000020.md) | [84.6](/filings/0000019584-26-000012.md) | [89.2](/filings/0000019584-26-000020.md) | [96.4](/filings/0000019584-26-000024.md) |
| Interest expense | $m | [0.3 d](/filings/0001562762-26-000020.md) | [0.4](/filings/0001562762-25-000096.md) | [0.4](/filings/0001562762-25-000186.md) | [0.4](/filings/0000019584-25-000006.md) | [0.5 d](/filings/0001562762-26-000020.md) | [0.3](/filings/0000019584-26-000012.md) | [0.4](/filings/0000019584-26-000020.md) | [0.5](/filings/0000019584-26-000024.md) | [0.5 d](/filings/0001562762-26-000020.md) | [0.5](/filings/0000019584-26-000012.md) | [1.8](/filings/0000019584-26-000020.md) | [2.1](/filings/0000019584-26-000024.md) |
| Income tax | $m | [25.5 d](/filings/0001562762-26-000020.md) | [19.5](/filings/0001562762-25-000096.md) | [22.9](/filings/0001562762-25-000186.md) | [25.3](/filings/0000019584-25-000006.md) | [29.8 d](/filings/0001562762-26-000020.md) | [23.9](/filings/0000019584-26-000012.md) | [18.6](/filings/0000019584-26-000020.md) | [19.3](/filings/0000019584-26-000024.md) | [28.7 d](/filings/0001562762-26-000020.md) | [22.5](/filings/0000019584-26-000012.md) | [23.6](/filings/0000019584-26-000020.md) | [25.1](/filings/0000019584-26-000024.md) |
| Net income | $m | [90.1 d](/filings/0001562762-26-000020.md) | [65.0](/filings/0001562762-25-000096.md) | [70.9](/filings/0001562762-25-000186.md) | [75.8](/filings/0000019584-25-000006.md) | [90.3 d](/filings/0001562762-26-000020.md) | [71.8](/filings/0000019584-26-000012.md) | [52.5](/filings/0000019584-26-000020.md) | [64.2](/filings/0000019584-26-000024.md) | [76.8 d](/filings/0001562762-26-000020.md) | [66.3](/filings/0000019584-26-000012.md) | [67.7](/filings/0000019584-26-000020.md) | [71.6](/filings/0000019584-26-000024.md) |
| Diluted EPS | $ per share | not reported | [4.24](/filings/0001562762-25-000096.md) | [4.65](/filings/0001562762-25-000186.md) | [5.00](/filings/0000019584-25-000006.md) | not reported | [4.86](/filings/0000019584-26-000012.md) | [3.57](/filings/0000019584-26-000020.md) | [4.46](/filings/0000019584-26-000024.md) | not reported | [4.84](/filings/0000019584-26-000012.md) | [5.13](/filings/0000019584-26-000020.md) | [5.45](/filings/0000019584-26-000024.md) |
| Basic EPS | $ per share | not reported | [4.30](/filings/0001562762-25-000096.md) | [4.70](/filings/0001562762-25-000186.md) | [5.04](/filings/0000019584-25-000006.md) | not reported | [4.91](/filings/0000019584-26-000012.md) | [3.60](/filings/0000019584-26-000020.md) | [4.46](/filings/0000019584-26-000024.md) | not reported | [4.85](/filings/0000019584-26-000012.md) | [5.14](/filings/0000019584-26-000020.md) | [5.49](/filings/0000019584-26-000024.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [264](/filings/0001562762-25-000038.md) | [313](/filings/0001562762-24-000106.md) | [223](/filings/0001562762-24-000183.md) | [238](/filings/0001562762-24-000248.md) | [178](/filings/0001562762-26-000020.md) | [174](/filings/0001562762-25-000096.md) | [250](/filings/0001562762-25-000186.md) | [130](/filings/0000019584-25-000006.md) | [74.5](/filings/0000019584-26-000024.md) | [16.9](/filings/0000019584-26-000012.md) | [40.2](/filings/0000019584-26-000020.md) | [48.4](/filings/0000019584-26-000024.md) |
| Current assets | $m | [501](/filings/0001562762-25-000038.md) | [540](/filings/0001562762-24-000106.md) | [465](/filings/0001562762-24-000183.md) | [490](/filings/0001562762-24-000248.md) | [395](/filings/0001562762-26-000020.md) | [502](/filings/0001562762-25-000096.md) | [491](/filings/0001562762-25-000186.md) | [395](/filings/0000019584-25-000006.md) | [303](/filings/0000019584-26-000024.md) | [274](/filings/0000019584-26-000012.md) | [291](/filings/0000019584-26-000020.md) | [366](/filings/0000019584-26-000024.md) |
| Total assets | $m | [1,668](/filings/0001562762-26-000020.md) | [1,728](/filings/0001562762-25-000096.md) | [1,735](/filings/0001562762-24-000183.md) | [1,769](/filings/0001562762-24-000248.md) | [1,669](/filings/0001562762-26-000020.md) | [1,727](/filings/0001562762-25-000096.md) | [1,718](/filings/0001562762-25-000186.md) | [1,624](/filings/0000019584-25-000006.md) | [1,538](/filings/0000019584-26-000024.md) | [1,536](/filings/0000019584-26-000012.md) | [1,580](/filings/0000019584-26-000020.md) | [1,718](/filings/0000019584-26-000024.md) |
| Current liabilities | $m | [312](/filings/0001562762-25-000038.md) | [282](/filings/0001562762-24-000106.md) | [262](/filings/0001562762-24-000183.md) | [265](/filings/0001562762-24-000248.md) | [286](/filings/0001562762-26-000020.md) | [291](/filings/0001562762-25-000096.md) | [264](/filings/0001562762-25-000186.md) | [292](/filings/0000019584-25-000006.md) | [287](/filings/0000019584-26-000024.md) | [321](/filings/0000019584-26-000012.md) | [320](/filings/0000019584-26-000020.md) | [331](/filings/0000019584-26-000024.md) |
| Total liabilities | $m | [560](/filings/0001562762-25-000038.md) | [544](/filings/0001562762-24-000106.md) | [528](/filings/0001562762-24-000183.md) | [534](/filings/0001562762-24-000248.md) | [550](/filings/0001562762-26-000020.md) | [545](/filings/0001562762-25-000096.md) | [519](/filings/0001562762-25-000186.md) | [547](/filings/0000019584-25-000006.md) | [559](/filings/0000019584-26-000024.md) | [688](/filings/0000019584-26-000012.md) | [749](/filings/0000019584-26-000020.md) | [857](/filings/0000019584-26-000024.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [91.2](/filings/0000019584-26-000012.md) | [140](/filings/0000019584-26-000020.md) | [236](/filings/0000019584-26-000024.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,108](/filings/0001562762-26-000020.md) | [1,183](/filings/0001562762-25-000186.md) | [1,207](/filings/0000019584-25-000006.md) | [1,236](/filings/0000019584-25-000006.md) | [1,119](/filings/0000019584-26-000024.md) | [1,182](/filings/0000019584-26-000020.md) | [1,198](/filings/0000019584-26-000024.md) | [1,077](/filings/0000019584-26-000024.md) | [979](/filings/0000019584-26-000024.md) | [848](/filings/0000019584-26-000020.md) | [831](/filings/0000019584-26-000024.md) | [861](/filings/0000019584-26-000024.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [109 d](/filings/0001562762-26-000020.md) | [84.5](/filings/0001562762-25-000096.md) | [77.5 d](/filings/0001562762-25-000186.md) | [90.5 d](/filings/0000019584-25-000006.md) | [165 d](/filings/0001562762-26-000020.md) | [32.7](/filings/0000019584-26-000012.md) | [139 d](/filings/0000019584-26-000020.md) | [83.4 d](/filings/0000019584-26-000024.md) | [134 d](/filings/0001562762-26-000020.md) | [88.2](/filings/0000019584-26-000012.md) | [84.8 d](/filings/0000019584-26-000020.md) | [56.6 d](/filings/0000019584-26-000024.md) |
| Capital expenditure | $m | [11.8 d](/filings/0001562762-26-000020.md) | [12.2](/filings/0001562762-25-000096.md) | [96.4](/filings/0001562762-25-000186.md) | [18.6](/filings/0000019584-25-000006.md) | [12.8 d](/filings/0001562762-26-000020.md) | [13.3](/filings/0000019584-26-000012.md) | [15.8](/filings/0001562762-25-000186.md) | [17.5](/filings/0000019584-25-000006.md) | [16.3 d](/filings/0001562762-26-000020.md) | [17.1](/filings/0000019584-26-000012.md) | [15.5 d](/filings/0000019584-26-000020.md) | [18.7 d](/filings/0000019584-26-000024.md) |
| Dividends paid | $m | [6.1 d](/filings/0001562762-26-000020.md) | [6.1](/filings/0001562762-25-000096.md) | [6.1 d](/filings/0001562762-25-000186.md) | [7.5 d](/filings/0000019584-25-000006.md) | [7.5 d](/filings/0001562762-26-000020.md) | [7.3](/filings/0000019584-26-000012.md) | [7.2 d](/filings/0000019584-26-000020.md) | [8.7 d](/filings/0000019584-26-000024.md) | [8.5 d](/filings/0001562762-26-000020.md) | [8.2](/filings/0000019584-26-000012.md) | [7.9 d](/filings/0000019584-26-000020.md) | [9.2 d](/filings/0000019584-26-000024.md) |
| Share repurchases | $m | [39.9 d](/filings/0001562762-26-000020.md) | [38.5](/filings/0001562762-25-000096.md) | [55.8 d](/filings/0001562762-25-000186.md) | [57.8 d](/filings/0000019584-25-000006.md) | [209 d](/filings/0001562762-26-000020.md) | [33.2](/filings/0000019584-26-000012.md) | [42.9 d](/filings/0000019584-26-000020.md) | [181 d](/filings/0000019584-26-000024.md) | [175 d](/filings/0001562762-26-000020.md) | [190](/filings/0000019584-26-000012.md) | [97.5 d](/filings/0000019584-26-000020.md) | [62.5 d](/filings/0000019584-26-000024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.1](/filings/0001562762-24-000106.md) | [15.2](/filings/0001562762-24-000183.md) | [15.2](/filings/0001562762-24-000248.md) | [15.3](/filings/0001562762-25-000096.md) | [15.3](/filings/0001562762-25-000186.md) | [15.2](/filings/0000019584-25-000006.md) | [14.8](/filings/0000019584-26-000012.md) | [14.7](/filings/0000019584-26-000020.md) | [14.4](/filings/0000019584-26-000024.md) | [13.7](/filings/0000019584-26-000012.md) | [13.2](/filings/0000019584-26-000020.md) | [13.1](/filings/0000019584-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,014,915 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0000019584-26-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 09:14 ET. No prices; not investment advice.